• Sign in

  • Join for free
  • Donate Today!
  • We are Social
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn
  • Who
    we are
    • Who we are
    • Our Story
    • Rosie
    • Rosie’s Blog
    • Our Trustees
    • Our Patrons
  • What
    we do
  • Secondary
    Breast Cancer
    • What is secondary breast cancer?
    • Symptoms
    • What is the current treatment
    • Maximising quality of life
    • Your Stories
    • Where to go for information
  • Get
    involved
    • Our Fundraisers
    • How to fundraise
    • Events
      • Fonthill Open Garden Party
      • Past Events
  • News
    • News
    • In the media
    • Video
    • Rosie’s Blog
  • Contact
Secondary1st
  • Donate Today!

Search

Login

Register
  • 020 8905 3955info@secondary1st.org.uk
0
Secondary1st
  • Menu
  • Who
    we are
    • Who we are
    • Our Story
    • Rosie
    • Rosie’s Blog
    • Our Trustees
    • Our Patrons
  • What
    we do
  • Secondary
    Breast Cancer
    • What is secondary breast cancer?
    • Symptoms
    • What is the current treatment
    • Maximising quality of life
    • Your Stories
    • Where to go for information
  • Get
    involved
    • Our Fundraisers
    • How to fundraise
    • Volunteer
    • Events
      • Fonthill Open Garden Party
      • Past Events
  • News & Media
    • News
    • In the media
    • Video
    • Rosie’s Blog
  • Contact
  • Donate Today!
20January

Secondary1st Research Grant

Next
Previous
January 20, 2021
By cuco_admin_sec
0 Comment

Thanks to our wonderful Donors and Fundraisers Secondary1st has been able to make a second grant of  £65,000 to the research project led by Dr Seth Coffelt at the Beatson Institute at the University of Glasgow.   Dr Coffelt and his team are investigating the role of a type of immune cell called gamma delta T cells in helping breast cancer to spread through the body.  These gamma delta T cells can suppress the immune system and prevent it from destroying cancer cells.  The immune system protects the body  against illness and infection but a tumour can sometimes trick it into ignoring it or even promoting its growth.  The aim of Dr Coffelt’s team is to understand how these gamma delta T cells and other immune cells take part in metastasis or the spread of cancer cells and so develop new immunotherapies that counteract metastatic lesions.

At Secondary1st we appreciate that a great deal of attention has had to be concentrated on the pandemic and the development of effective vaccines to deal with Covid-19, but we also know that it is vital for research into secondary breast cancer to continue.  Secondary1st remains in a stable financial position and ready to continue our mission to increase awareness of and raise more money for research into secondary breast cancer.  We hope that before long life will return to a more normal pattern and that 2021 will be a much better year for everyone.

Categories: News
  • Search

  • Sign up for Newsletter

    * = required field
  • Categories

    • Event
    • Fundraising
    • In the media
    • News
    • Past Events
    • Rosie's blog
    • Uncategorised
    • Your Stories
  • Latest News

    • More Challenges for Tracey

      April 07, 2021

    • Up in the Air

      April 07, 2021

    • A More Efficient Treatment Method

      April 07, 2021

    • A Nice recommendation

      March 01, 2021

  • Who We Are

    • Who we are
    • Our Story
    • Rosie
    • Rosie’s blog
    • Our Trustees
    • Our Patrons
  • What We Do

    • What we do
  • Secondary Breast Cancer

    • What is secondary breast cancer?
    • Symptoms
    • What is the current treatment
    • Maximising quality of life
    • Where to go for information
  • Get Involved

    • How to fundraise
    • Our Fundraisers

© 2016 - 2021 Secondary First is a Company Limited by Guarantee. Registered in England and Wales No. 9920657. Registered Office: 1st Floor Healthaid House, Marlborough Hill, Harrow, HA1 1UD. It is a Registered Charity Number 1165614.
Site maintained by CuCo Creative.

  • Cookie Policy
  • Privacy Policy